Milestone Scientific Inc. (MLSS) stock
MLSSNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3018% below fair value
$0.28−0.02 (-5.78%)
Close on Nov 17, 2026Market cap $24.58MP/E –Yield –
Milestone Scientific operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Milestone Scientific's operating income for the twelve months ending Jun 30, 2026 was -$4.10M. For fiscal 2025 it was -$5.70M. The highest annual figure on record is $1.09M in fiscal 2013.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.70M | – |
| FY2024 | Dec 31, 2024 | -$6.76M | – |
| FY2023 | Dec 31, 2023 | -$7.11M | – |
| FY2022 | Dec 31, 2022 | -$8.83M | – |
| FY2021 | Dec 31, 2021 | -$7.38M | – |
| FY2020 | Dec 31, 2020 | -$7.45M | – |
| FY2019 | Dec 31, 2019 | -$4.00M | – |
| FY2018 | Dec 31, 2018 | -$8.00M | – |
| FY2017 | Dec 31, 2017 | -$5.23M | – |
| FY2016 | Dec 31, 2016 | -$6.51M | – |
| FY2015 | Dec 31, 2015 | -$3.06M | – |
| FY2014 | Dec 31, 2014 | -$790.18K | -172.7% |
| FY2013 | Dec 31, 2013 | $1.09M | – |
| FY2012 | Dec 31, 2012 | -$520.35K | – |
| FY2011 | Dec 31, 2011 | -$1.22M | – |
| FY2010 | Dec 31, 2010 | -$700.84K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.06M | – |
| Q1 FY2026 | Mar 31, 2026 | -$828.08K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.08M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.13M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.48M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.00M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.04M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.47M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.47M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.98M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.51M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.28M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.34M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.01M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.01M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.88M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.91M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.54M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.98M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.87M | – |
| Q1 FY2021 | Mar 31, 2021 | -$984.37K | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.19M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.48M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.17M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.61M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.13M | – |
| Q3 FY2019 | Sep 30, 2019 | -$946.73K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.11M | – |
| Q1 FY2019 | Mar 31, 2019 | -$818.18K | – |
| Q4 FY2018 | Dec 31, 2018 | -$25.41K | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.55M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.42M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.00M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.74M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.41M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.55M | – |
| Q1 FY2017 | Mar 31, 2017 | -$525.93K | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.83M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.57M | – |
See a number that looks wrong?